Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23395)

• Formulation Name: Cabozantinib S-Malate eq 20mg base capsule
• Company: Exelixis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Cabozantinib	(DMIYDT4)	Medullary thyroid gland carcinoma		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonium hydroxide	(E00687)	Not Available	Alkalizing agent
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric oxide black	(E00522)	16211978	Colorant
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Shellac	(E00695)	Not Available	Coating agent; Film/membrane-forming agent; Microencapsulating agent; Modified-release agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent